Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer’s patches

Applied Microbiology and Biotechnology

Volumn 99, Issue 21, 2015, Pages 9097-9110

  Thevenot J ^a,b   Cordonnier, C ^a,b   Rougeron, A ^b   Le Goff, O ^a   Nguyen, H T T ^b   Denis, S ^a   Alric, M ^a   Livrelli, V ^b,c   Blanquet Diot, S ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Colonic in vitro model; Enterohemorrhagic Escherichia coli (EHEC); Gut microbiota; Mice ileal loops; Probiotic; Saccharomyces cerevisiae

Indexed keywords

ESCHERICHIA COLI; FATTY ACIDS; PATHOGENS; STRAIN; VOLATILE FATTY ACIDS;

ENTEROHEMORRHAGIC ESCHERICHIA COLI; GUT MICROBIOTA; IN-VITRO MODELS; MICE ILEAL LOOPS; PROBIOTICS;

YEAST;

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; INTERLEUKIN 8; MESSENGER RNA; PROBIOTIC AGENT; SHIGA TOXIN; SHORT CHAIN FATTY ACID; VIRULENCE FACTOR; VOLATILE FATTY ACID;

ANTAGONISM; BACTERIAL DISEASE; BIOASSAY; BIOTECHNOLOGY; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM DISORDER; FATTY ACID; HOMINID; INHIBITION; PATHOGEN; PROBIOTICS; RODENT; TOXIN; VIRULENCE; YEAST;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; COLON FLORA; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; GENE EXPRESSION; HEMORRHAGIC COLITIS; HUMAN; HUMAN TISSUE; ILEAL TISSUE; IN VITRO STUDY; INTESTINE BRUSH BORDER; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE WALL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PEYER PATCH; PROPHYLAXIS; UPREGULATION; YEAST; ANIMAL; ANTIBIOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; COLON; DISEASE MODEL; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; ILEUM; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; SACCHAROMYCES CEREVISIAE; TIME FACTOR; TREATMENT OUTCOME;

ESCHERICHIA COLI; MURINAE; MUS; SACCHAROMYCES CEREVISIAE;

ANIMALS; ANTIBIOSIS; COLON; DISEASE MODELS, ANIMAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; ILEUM; MICE; MODELS, BIOLOGICAL; PEYER'S PATCHES; PRE-EXPOSURE PROPHYLAXIS; PROBIOTICS; SACCHAROMYCES CEREVISIAE; SHIGA TOXIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84945448911     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6704-0     Document Type: Article

References (52)

1. Bacchetti De Gregoris T, Aldred N, Clare AS, Burgess JG (2011) Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods 86:351–356
2. Barnett Foster D (2013) Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence 4:315–323
3. Bartosch S, Fite A, Macfarlane GT, McMurdo MET (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575–3581
4. Bellmeyer A, Cotton C, Kanteti R, Koutsouris A, Viswanathan VK, Hecht G (2009) Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. Am J Physiol Gastrointest Liver Physiol 297:G576–G581
5. Blanquet-Diot S, Denis S, Chalancon S, Chaira F, Cardot J-M, Alric M (2012) Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans. Pharm Res 29:1444–1453
6. Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, Joly B, Forestier C (1998) Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J Clin Microbiol 36:1777-1780
7. Carey CM, Kostrzynska M, Ojha S, Thompson S (2008) The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods 73:125–132
8. Chong Y, Fitzhenry R, Heuschkel R, Torrente F, Frankel G, Phillips AD (2007) Human intestinal tissue tropism in Escherichia coli O157:H7 – initial colonization of terminal ileum and Peyer’s patches and minimal colonic adhesion ex vivo. Microbiology 153:794–802
9. Dahan S, Dalmasso G, Imbert V, Peyron J-F, Rampal P, Czerucka D (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71:766–773
10. Dalmasso G, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157:456–465
11. Danckwerts PV (1953) Continuous flow systems: distribution of residence times. Chem Eng Sci 2:1–13
12. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert AP, Martin C (2009) Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 77:783–790
13. Etienne-Mesmin L, Livrelli V, Privat M, Denis S, Cardot J-M, Alric M, Blanquet-Diot S (2011a) Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl Environ Microbiol 77:1127–1131
14. Etienne-Mesmin L, Chassaing B, Sauvanet P, Denizot J, Blanquet-Diot S, Darfeuille-Michaud A, Pradel N, Livrelli V (2011b) Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorragic Escherichia coli infections. PLoS One 6:e23594
15. FAO/WHO (2002) Report of a joint FAO/WHO working group on drafture Organization of the United Nations and World Health Organization London, Ontario, Canada
16. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543–547
17. Furet J-P, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Doré J, Corthier G (2009) Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68:351–362
18. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104–119
19. Herold S, Paton JC, Srimanote P, Paton AW (2009) Differential effects of short-chain fatty acids and iron on expression of iha in Shiga-toxigenic Escherichia coli. Microbiology 155:3554–3563
20. Hitotsubashi S, Fujii Y, Yamanaka H, Okamoto K (1992) Some properties of purified Escherichia coli heat-stable enterotoxin II. Infect Immun 60:4468–4474
21. Hsueh H-Y, Yueh P-Y, Yu B, Zhao X, Liu J-R (2010) Expression of Lactobacillus reuteri Pg4 collagen-binding protein gene in Lactobacillus casei ATCC 393 increases its adhesion ability to Caco-2 cells. J Agric Food Chem 58:12182–12191
22. Hugo AA, Kakisu E, De Antoni GL, Pérez PF (2008) Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro. Lett Appl Microbiol 46:613–619
23. Huijsdens XW, Linskens RK, Mak M, Meuwissen SGM, Vandenbroucke-Grauls CMJE, Savelkoul PHM (2002) Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40:4423–4427
24. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340–1348
25. Konietschke F (2012) nparcomp: Perform multiple comparisons and compute simultaneous confidence intervals for the nonparametric relative contrast effects. R package version 2.0
26. Kus JV, Gebremedhin A, Dang V, Tran S-L, Serbanescu A, Foster DB (2011) Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 193:4509–4515
27. Lewis SB, Cook V, Tighe R, Schüller S (2015) Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo. Infect Immun 83:942–949
28. Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359
29. Martins FS, Vieira AT, Elian SDA, Arantes RME, Tiago FCP, Sousa LP, Araújo PPF, Bonjardim CA, Nicoli JR, Teixeira MM (2013) Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes Infect 15:270–279
30. Medellin-Peña MJ, Griffiths MW (2009) Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol 75:1165–1172
31. Medellin-Peña MJ, Wang H, Johnson R, Anand S, Griffiths MW (2007) Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol 73:4259–4267
32. Miszczycha SD, Thévenot J, Denis S, Callon C, Livrelli V, Alric M, Montel M-C, Blanquet-Diot S, Thevenot-Sergentet D (2014) Survival of Escherichia coli O26:H11 exceeds that of Escherichia coli O157:H7 as assessed by simulated human digestion of contaminated raw milk cheeses. Int J Food Microbiol 172:40–48
33. Nakanishi N, Tashiro K, Kuhara S, Hayashi T, Sugimoto N, Tobe T (2009) Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology 155:521–530
34. Naylor SW, Gally DL, Low JC (2005) Enterohaemorrhagic E. coli in veterinary medicine. Int J Med Microbiol 295:419–441
35. Nguyen HTT, Dalmasso G, Müller S, Carrière J, Seibold F, Darfeuille-Michaud A (2014) Crohn’s disease—associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146:508–519
36. Noguchi K, Gel YR, Brunner E, Konietschke F (2012) NparLD: an R software package for the nonparametric analysis of longitudinal data in factorial experiments. J Stat Softw 50:1–23
37. Phillips A, Navabpour S, Hicks S, Dougan G, Wallis T, Frankel G (2000) Enterohaemorrhagic Escherichia coli O157:H7 target Peyer’s patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 47:377–381
38. Putaala H, Salusjärvi T, Nordström M, Saarinen M, Ouwehand AC, Bech Hansen E, Rautonen N (2008) Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 159:692–698
39. R-Development-Core-Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
40. Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA (2013) Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Int J Med Microbiol 303:1–8
41. Scheiring J, Rosales A, Zimmerhackl LB (2010) Clinical practice: today’s understanding of the haemolytic uraemic syndrome. Eur J Pediatr 169:7–13
42. Serna A, Boedeker EC (2008) Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24:38–47
43. Shigeno T, Akamatsu T, Fujimori K, Nakatsuji Y, Nagata A (2002) The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection. Endoscopy 34:311–314
44. Sun J, Zhou T-T, Le G-W, Shi Y-H (2010) Association of Lactobacillus acidophilus with mice Peyer’s patches. Nutrition 26:1008–1013
45. Swerdlow DL, Griffin PM (1997) Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 349:745–746
46. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO (1990) Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 162:553–556
47. Thévenot J, Etienne-Mesmin L, Denis S, Chalancon S, Alric M, Livrelli V, Blanquet-Diot S (2013) Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota. Appl Environ Microbiol 79:1058–1064
48. Tiago FCP, Martins FS, Souza ELS, Pimenta PFP, Araújo HRC, Castro IM, Brandão RL, Nicoli JR (2012) Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J Med Microbiol 61:1194–1207
49. Tobe T, Nakanishi N, Sugimoto N (2011) Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemorrhagic Escherichia coli. Infect Immun 79:1016–1024
50. Toshima H, Yoshimura A, Arikawa K, Hidaka A, Ogasawara J, Hase A, Masaki H, Nishikawa Y (2007) Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl Environ Microbiol 73:7582–7588
51. Turková K, Mavrič A, Narat M, Rittich B, Španová A, Rogelj I, Matijašić BB (2013) Evaluation of Lactobacillus strains for selected probiotic properties. Folia Microbiol 58:261–267
52. Yu Y, Lee C, Kim J, Hwang S (2005) Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnol Bioeng 89:670–679